News
Trastuzumab emtansine reduced the risk of cancer worsening or death
Roche announced that the Phase III EMILIA study of trastuzumab emtansine met its co-primary endpoint, of a significant improvement in the time patients with...
News
Boehringer Ingelheim expands development capacities with new technical centre
The research driven pharmaceutical company Boehringer Ingelheim is establishing a new 50 million-plus euro pilot plant facility for the production of newly developed active...
News
Bristol-Myers Squibb announces global collaboration with leading academic institutions
Bristol-Myers Squibb Company announced the formation of the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims to further the...
News
Lundbeck’s Lu AE58054 meets primary endpoint
H. Lundbeck A/S today announced that Lu AE58054 has met its primary endpoint in a fixed dose, randomized, placebo-controlled clinical study in 278 patients...
News
Thioridazine, successfully kills cancer stem cells in the human
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic...
News
Innovative public-private collaboration launches to tackle antibiotic research
GlaxoSmithKline and AstraZeneca welcomed the launch of a pioneering approach to antibiotic research in Europe that will see pharmaceutical and biotechnology companies working alongside public...
News
Bayer’s Regorafenib submitted for EU and US marketing authorization
Bayer HealthCare has submitted a Marketing Authorization Application to the European Medicines Agency and a New Drug Application to the U.S. Food and Drug...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.